Chemcrux Enterprises Limited

CHEMCRUX6

INE298W01016

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 12:37:18 2024-06-21 am EDT			5-day change	1st Jan Change
243 ^INR	+3.98%		+2.38%	-21.60%

May. 06	Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2023-24	CI
May. 06	Chemcrux Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Chemcrux Enterprises Limited Approves Final Dividend for the Year Ended 31St March, 2021

August 25, 2021 at 03:33 am EDT

Chemcrux Enterprises Limited approved dividend of 2.00 per Equity Share for the year ended 31st March, 2021 at its AGM held on 24th August, 2021.

Latest news about Chemcrux Enterprises Limited

Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2023-24	May. 06	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 06	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Chemcrux Enterprises Names CFO	Dec. 08	MT
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Chemcrux Enterprises Limited Announces Resignation of Mr. Krutarth Parikh as Chief Financial Officer, Effective 13 September 2023	23-09-01	CI
Chemcrux Enterprises Limited Announces Board Changes	23-08-04	CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-04	CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2022-23	23-05-20	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-12	CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as Independent Director	22-09-24	CI
Chemcrux Enterprises Limited Approves Final Dividend for the Financial Year Ended 31 March 2022	22-09-24	CI
Chemcrux Enterprises Limited Proposes Final Dividend for the Financial Year Ended 31 March 2022	22-08-31	CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2021-22	22-05-20	CI
Chemcrux Enterprises Gets Local Bourse BSE's Approval in Principle to Move to Main Board	22-04-28	MT
Chemcrux Enterprises Gets Environment Clearance to Expand Manufacturing of Synthetic Organic Chemicals	22-01-04	MT
Chemcrux Enterprises and Kalintis Healthcare to Set Up New Joint Venture	21-12-22	MT
Chemcrux Enterprises Limited Announces Resignation of Sidhdhi Girishkumar Shah as Non-Executive Non-Independent Director	21-12-22	CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as an Additional Director	21-12-22	CI
Chemcrux Enterprises Limited completed the acquisition of a 50% stake in Kalichem Private Limited.	21-12-21	CI
Chemcrux Enterprises Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-01	CI
Chemcrux Enterprises : to Acquire 50% Stake in Indian Chemicals Manufacturer	21-09-08	MT
Chemcrux Enterprises Limited (BSE : 540395) agreed to acquire a 50% stake in Kalichem Private Limited.	21-09-07	CI

Chart Chemcrux Enterprises Limited

Duration

Period

More charts

Chemcrux Enterprises Limited is an India-based company. The Company is engaged in manufacturing intermediates for bulk drugs, dyes and pigment industries. It is engaged in manufacturing or processing of bulk drug intermediates like Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. The Company's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid. It is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Companyâs manufacturing facility is located in Bharuch, Gujarat, India.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHEMCRUX ENTERPRISES LIMITED	-21.60%	41.37M
ELI LILLY AND COMPANY	+51.99%	798B
JOHNSON & JOHNSON	-5.72%	356B
MERCK & CO., INC.	+18.94%	328B
ABBVIE INC.	+11.07%	304B
ASTRAZENECA PLC	+16.96%	244B
ROCHE HOLDING AG	+2.25%	227B
NOVARTIS AG	+11.15%	216B
AMGEN INC.	+7.59%	166B
PFIZER, INC.	-3.65%	157B